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Saccharomyces cerevisiae continues to serve as a powerful model system for both
basic biological research and industrial application. The development of genome-wide
collections of individually manipulated strains (libraries) has allowed for high-throughput
genetic screens and an emerging global view of this single-celled Eukaryote. The success
of strain construction has relied on the innate ability of budding yeast to accept foreign
DNA and perform homologous recombination, allowing for efficient plasmid construction
(in vivo) and integration of desired sequences into the genome. The development of
molecular toolkits and “integration cassettes” have provided fungal systems with a
collection of strategies for tagging, deleting, or over-expressing target genes; typically,
these consist of a C-terminal tag (epitope or fluorescent protein), a universal terminator
sequence, and a selectable marker cassette to allow for convenient screening. However,
there are logistical and technical obstacles to using these traditional genetic modules
for complex strain construction (manipulation of many genomic targets in a single
cell) or for the generation of entire genome-wide libraries. The recent introduction of
the CRISPR/Cas gene editing technology has provided a powerful methodology for
multiplexed editing in many biological systems including yeast. We have developed
four distinct uses of the CRISPR biotechnology to generate yeast strains that utilizes
the conversion of existing, commonly-used yeast libraries or strains. We present Cas9-
based, marker-lessmethodologies for (i) N-terminal tagging, (ii) C-terminally tagging yeast
genes with 18 unique fusions, (iii) conversion of fluorescently-tagged strains into newly
engineered (or codon optimized) variants, and finally, (iv) use of a Cas9 “gene drive”
system to rapidly achieve a homozygous state for a hypomorphic query allele in a diploid
strain. These CRISPR-basedmethods demonstrate use of targeting universal sequences
previously introduced into a genome.
Keywords: CRISPR, Cas9, budding yeast, libraries, marker-less integration, gene drive, gene tagging
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INTRODUCTION
Saccharomyces cerevisiae (budding yeast) continues to serve as an
excellent model Eukaryote to study many biological phenomena
and conserved molecular pathways. Part of the success and
profound contributions of this single-celled Ascomycete is the
ease by which its genome can be edited and the plethora of
molecular tools that have been developed and expanded over
the last few decades. Since S. cerevisiae can (i) uptake exogenous
DNA (plasmids and amplified PCR fragments) very easily, (ii)
assemble circular plasmids in vivo, and (iii) integrate engineered
constructs into its genome with high fidelity, this has led to this
organism being the world’s most genetically tractable system.
Yeast has provided a platform for the development of new
technologies, such as the two- and three-hybrid systems (Fields
and Song, 1989; Vidal and Fields, 2014; Maruta et al., 2016),
synthetic genetic array (SGA) (Tong et al., 2001), and the
(ongoing) synthesis/engineering of the first Eukaryotic genome
de novo (Shen et al., 2017; Xie et al., 2017). Yeast has provided
a system to study evolution (Hope et al., 2017), cellular aging
(McCormick et al., 2015), biofuel development (Kim et al.,
2017), drug production (Galanie et al., 2015), and human genetic
diseases (Mayfield et al., 2012), to name only a few.
Part of the success of this model organism includes the
development and utility of genome-wide libraries—collections
of separate yeast strains each containing a unique modification
(an engineered plasmid, an integrated epitope tag, or deletion
of a gene, etc.)—that can be used to screen all non-essential (or
essential) genes that would be required for different molecular
processes. Over the years, the set of available yeast libraries has
expanded to include epitope tags (Ross-Macdonald et al., 1999;
Ghaemmaghami et al., 2003), over-expression arrays (Sopko
et al., 2006; Ho et al., 2009), fluorescent protein fusions (Huh
et al., 2003), gene deletions (Giaever et al., 2002), and essential
hypomorphic alleles (Breslow et al., 2008; Li et al., 2011). These
collections have been useful in uncovering cellular, biochemical,
and genetic interactions across numerous fields. The power of
yeast genetics, libraries, and robotic automation has recently been
demonstrated in the world’s largest collection of double deletion
mutants (>20 million yeast strains) in a single study (Costanzo
et al., 2016). However, construction of such a large collection
(∼5,000 separate strains) still presents many logistical challenges.
Abbreviations: 5-FOA, 5-Fluoroorotic Acid; NLS, nuclear localization
signal; NES, nuclear export signal; GFP, green fluorescent protein; eGFP, enhanced
GFP; mCherry, monomeric red fluorescence protein variant; pr, promoter;
t, terminator; bp, base pairs; sgRNA, single guide RNA; HR, homologous
recombination; DSB, double-stranded break; HDR, homology-directed repair;
NHEJ, non-homologous end joining; prMX/MX(t), promoter and terminator
sequences for the Ashbya gossypii TEF1α (translation elongation factor 1α) used
in the MX-based yeast cassettes; oligo, DNA oligonucleotide primer; CRISPR,
clustered regularly interspaced short palindromic repeats; PAM, protospacer
adjacent motif; TAP-tag, tandem affinity purification epitope tag; KAN/KANR,
Kanamycin resistance gene conferring yeast resistance to G418 disulfate; DIC,
differential interference contrast light microscopy; Chr, chromosome; indel,
insertion/deletion; FP, fluorescent protein; SGA, synthetic genetic array—use of
this term specifically refers to the entire procedure (mating, diploid selection,
sporulation, and selection of desired haploid isolates); HCS, high-content
screening; OE, over-expression; BiFC, Bimoleclar fluorescence complementation.
Previous studies have provided many collections of tagging
“cassettes” for direct fusion of a gene or gene fragment (usually
a fluorescent protein (FP) or biochemical epitope tag) to an
endogenous open reading frame (Schneider et al., 1995; Longtine
et al., 1998; Knop et al., 1999; De Antoni and Gallwitz, 2000;
Janke et al., 2004; Sung et al., 2005; Tagwerker et al., 2006;
Moqtaderi and Struhl, 2008). However, these methods all require
two common components: (i) individual oligonucleotides to be
purchased (or synthesized de novo) per locus being targeted
and (ii) the use of a selectable marker (auxotrophic marker or
drug selection marker) to identify and screen for proper isolates
(Gardner and Jaspersen, 2014). While this strategy has been
applied universally by nearly all yeast laboratories for several
decades, the utility of this system can become limited in certain
scenarios. First, tagging of large sets (or the entire genome) is
often extremely cost-prohibitive (libraries are either purchased or
shared at major academic centers). Second, tagging of a new gene
using this cassette-based methodology in a strain which already
contains one ormore other tagged loci can present problems with
the efficiency of targeting and integration as well as restrictions
placed on the available selection marker(s). In some cases, a
“marker-less” system may be more appropriate, but this typically
requires two or more additional steps and does not guarantee
a completely “scar-less” integration event. Third, the majority
of available cassettes focus primarily on biochemical epitopes
and/or fluorescent protein fusions. While these are useful for
many molecular assays, there are additional fusions of interest
that can be used as genetic screening tools, biochemical assays, or
subcellular localization signals that have not been included in any
previous methodological study.
The repurposing of the Streptococcus pyogenes CRISPR/Cas9
gene editing system (Jinek et al., 2012) has provided the
entire field of molecular biology with a powerful method
to target and manipulate precise DNA sequences in any
genome. Ironically, this technology has been met with a
lukewarm reception by the yeast community, given that powerful
molecular toolkits and methods already exist, and decades
worth of strains and libraries have already been generated.
However, the CRISPR system is still being utilized in some
yeast laboratories for unique editing applications such as
chromosome splitting (Sasano et al., 2016), transcriptional
modulation (Jensen et al., 2017), automated library construction
(Si et al., 2017), and metabolic engineering (Ryan and Cate,
2014). Briefly, expression of the type II CRISPR nuclease
Cas9, coupled with a single stranded fragment of RNA
(single guide), allows for the protein/RNA complex to be
recruited to the corresponding DNA sequence within any
genome of interest. There, Cas9 induces a double stranded
break (DSB) at the matching site that is anchored by
a 3 bp protospacer adjacent motif (PAM) sequence. Cells
respond by either performing (i) non-homologous end joining
(NHEJ) to directly fuse the broken chromosome fragments
or (ii) homology directed repair (HDR) using a donor DNA
fragment (amplified PCR product) containing homologous
sequences flanking either side of the break (Jinek et al., 2013).
Cas9-dependent introduction of a DSB allows for deletion,
replacement, or modification of existing DNA sequences in all
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genomes tested thus far, including budding yeast (DiCarlo et al.,
2013).
In this study, we describe four independent Cas9-based
methodologies for the introduction of both N- and C-terminal
tags into budding yeast that combine the use of a universal
targeting strategy based on a single sgRNA construct with
strains from various yeast library collections. Our method,
CRISPR-UnLOCK (Universal yeast Library Optimization and
Conversion Kit), provides (i) precise targeting and integration
in the absence of any selectable marker, (ii) a collection of 18
C-terminal tags that span a gamut of cellular localization signals,
fusions, fluorescent markers, and biochemical epitope tags, (iii) a
system nearly void of any “unique” oligonucleotides—targeting
multiple loci can be accomplished with the same universal set
of DNA primers, (iv) the ability to multiplex to multiple loci
simultaneously, and (v) a strategy for “upgrading” of existing
fluorescent proteins (FP) with an optimized codon bias or
newly engineered/discovered FP. Furthermore, we demonstrate
the use of a unique Cas9 arrangement—the “gene drive”—to
achieve a homozygous diploid state for a query allele without the
need for isolation of haploids (typically by the SGA method or
traditional yeast spore isolation). This molecular toolkit provides
powerful options to the conversion of existing yeast strains
and/or libraries into new sets. This technology can be used
for the construction of individual strains, small collections, or
possibly, entire libraries. Our system is fully compatible and
complementary with traditional cloning methods and screening
techniques, such as SGA. There are many cloning scenarios
that might benefit from a marker-less integration event. Finally,
our CRISPR application should be widely applicable to other
model systems in practice for cloning and targeting of “universal”
genomic loci with a minimum number of guide RNAs.
MATERIALS AND METHODS
Yeast Strains and Plasmids
S. cerevisiae strains constructed and used in this study can be
found in Table 1. Standard molecular biology techniques were
used to manipulate all DNA and yeast (Sambrook and Russell,
2001). Strains from the TAP tag collection (Ghaemmaghami
et al., 2003) were obtained and tested as clonal isolates (on
SD-HIS plates) by PCR amplifying the C-terminal portion of
the tagged gene of interest, the TAP tag, and into the universal
ADH1 terminator (Bennetzen andHall, 1982) with a high-fidelity
polymerase (KOD Hot Start, EMD Millipore), purified (GeneJet
PCR Purification Kit, Thermo Fisher Scientific), and confirmed
by Sanger DNA Sequencing (Genscript). Yeast from the haploid
genome deletion collection (MATα) (Giaever et al., 2002) were
tested as clonal isolates on rich medium containing G418 (Life
Technologies, Inc.), and the proper gene knockout confirmed
by diagnostic PCR. For strains containing an integrated cassette
at the endogenous HIS3 locus (e.g., GFY-2613), the following
general method was used for (i) creation of the assembled
plasmid used as a template and (ii) transformation and
integration into the yeast genome. First, in vivo plasmid assembly
(Finnigan and Thorner, 2015) was used to generate a construct
containing ∼1,000 bp of HIS3 5′ UTR (from starting vector
pGF-V769) followed by 449 bp of the SHS1 5′ UTR, GFP(S65T)
sequence, the ADH1 terminator, the KanR drug resistance MX
cassette, and ∼1,000 bp of HIS3 3′ UTR (to generate plasmid
pGF-IVL1348) and was verified by DNA sequencing. Second, the
entire assembled cassette including 196 bp of HIS3 5′ UTR and
151 bp of 3′ UTR was amplified (digested with DpnI overnight
to remove the template plasmid) and transformed into WT
BY4741 yeast (his3∆1) using a modified lithium acetate protocol
(Eckert-Boulet et al., 2012). G418-resistant yeast were selected as
clonal isolates (and confirmed to also be sensitive on SD-LEU
plates) and chromosomal DNA was confirmed using multiple
diagnostic PCRs to the integrated cassette and flanking regions
at the HIS3 locus (outside the region used for integration)
to generate GFY-2613. For strains harboring a modified gene
cassette at a different locus (e.g., CDC11 for GFY-2624), a
similar strategy was used with several changes. The starting
strain was BY4742 cdc11∆::KanR (GFY-150) and because of the
presence of the universal MX(t) sequence present in all of the
KanR deletion cassettes (Goldstein and McCusker, 1999), the
integration plasmid did not contain any CDC11 3′ UTR yet still
utilized the 5′ UTR for homologous recombination. Finally, for
the gene drive containing strains (GFY-2440 and GFY-2442),
due to the large size of the integrated cassette (>10 Kb), rather
than amplifying a single PCR fragment, two partially overlapping
PCRs (∼5 kb each) were generated and co-transformed into
yeast using the entire assembled cassette on a plasmid as the
DNA template (pGF-IVL1149). The integration event utilized the
∼100 bp overlapping sequence between the two PCRs (within the
Cas9 gene) to perform HR, and insert the entire sequence at the
correct locus.
Plasmids used in this study can be found in Table 2. In
vivo plasmid assembly was used for construction of all vectors
unless otherwise noted (Finnigan and Thorner, 2015). Briefly,
a starting vector containing the promoter of interest was
linearized by digestion (overnight) of a downstream restriction
cut site (typically NotI or SpeI). Next, PCR fragments to be
assembled were amplified with a high-fidelity polymerase and
oligonucleotides with overhanging tails of identical sequence to
the adjacent fragment sequence. Construction of the desired
plasmid was performed in yeast by co-transformation of a linear
vector and the appropriate PCR fragments followed by selection
for either (i) re-circularization of the original vector (e.g., on
SD-LEU) or (ii) the presence of a drug cassette (e.g., KanR MX
on G418) on one of the included PCRs. Following harvesting
from yeast, transformation into competent E. coli (TOP10, Life
Technologies, Inc.), and plasmid isolation (GeneJet Miniprep
Plasmid Isolation Kit, Thermo Fisher Scientific), constructs were
screened by diagnostic PCR and confirmed via Sanger DNA
Sequencing. For plasmids to be used as donor DNA templates for
PCR amplification, an additional cloning into the TOPO II vector
(pCR-Blunt II-TOPO, Life Technologies, Inc.) was performed
according to the recommended protocol. Genes synthesized de
novo (Genscript) were obtained in a pUC57 (AmpR) vector and
were used as DNA templates for amplification of assembled
fragments or used as donor DNA for Cas9-based integration.
For construction of sgRNA-expressing plasmids, the following
strategy was employed (Figure S1). Guide RNA expression was
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TABLE 1 | Yeast strains used in this study.
Strain Genotype References
BY4741 MATα his3∆1 leu2∆0 met15∆0 ura3∆0 Brachmann et al., 1998
BY4742 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 Brachmann et al., 1998
GFY-42 BY4741; CDC10::mCherry::ADH(t)::SpHIS5 Finnigan et al., 2015b
GFY-330 BY4741; CDC12::GFP::ADH(t)::HygR + pCDC12::URA3 (pJT1622) This study
GFY-1583 BY4741; KEL1::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-1589 BY4741; BUD3::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-1620 BY4741; ELM1::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-2047 BY4741; CAF120::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-2056 BY4741; NBA1::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-2069 BY4741; BEM2::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-2071 BY4741; MYO4::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-2092 BY4741; BUD2::TAPa::ADH(t)::SpHIS5 TAP Tag Collection
GFY-2251b BY4742; mso1∆::KanR Genome Deletion Collection
GFY-2259b BY4742; bni4∆::KanR Genome Deletion Collection
GFY-2256b BY4742; apl1∆::KanR Genome Deletion Collection
GFY-2613c BY4741; his3∆::prSHS1::GFP(S65T)::ADH(t)::KanR This study
GFY-2615c,d BY4741; his3∆::prSHS1::eGFP::ADH(t)::KanR This study
GFY-2617e BY4741; his3∆::prCDC12::GFP(S65T)::ADH(t)::KanR This study
GFY-2621c BY4741; his3∆::prSHS1::mCherry::ADH(t)::KanR This study
GFY-2622e BY4741; his3∆::prCDC12::mCherry::ADH(t)::KanR This study
GFY-2440f BY4741; cdc11∆::cdc11(357–415∆)::mCherry::CDC10
3′UTR::prGAL1/10::SpCas9::NLS::SHS1 3′UTR::prCCW12::KanR +
(pGF-IVL1146; pRS316; prCDC11::CDC11(WT))
This study
GFY-2442f BY4742; cdc11∆::cdc11(357–415∆)::mCherry::CDC10
3′UTR::prGAL1/10::SpCas9::NLS::SHS1 3′UTR::prCCW12::KanR +
(pGF-IVL1146; pRS316; prCDC11::CDC11(WT))
This study
GFY-2625g BY4741; cdc11∆::CDC11(WT)::GFP::ADH(t)::SpHIS5 + (pSB1/JT1520;
pRS316; prCDC11::CDC11(WT))
This study
GFY-2624g BY4742; cdc11∆::CDC11(WT)::GFP::ADH(t)::SpHIS5 + (pSB1/JT1520;
pRS316; prCDC11::CDC11(WT))
This study
aThe TAP (tandem affinity purification) tag consists of a linker sequence (11 residues), CBP domain (26), linker (9), TEV cleavage site (7), linker (10), first Protein Z domain (58), second
Protein Z (58), and final linker (6). The two Protein Z domains are identical in sequence. All TAP-tag strains were tested as single clonal isolates; the genomic loci that were tagged were
PCR amplified and confirmed via Sanger sequencing including (roughly) the last 200 bp of the tagged gene. The nine genes chosen occur on nine separate yeast chromosomes.
bStrains from the haploid genome deletion collection were confirmed as single clonal isolates for resistance to G418 disulfide and proper knock-out of the intended gene by diagnostic
PCRs.
cContains 449 bp of SHS1 5′ UTR. Strain GFY-2613 was constructed by PCR amplifying the prSHS1::GFP(S65T)::ADH(t)::KanR fragment from pGF-IVL1348 along with 500 bp of
flanking homology engineered upstream of prSHS1 and downstream of the KanR cassette and transforming into WT BY4741 yeast. Strains GFY-2615, GFY-2621, and GFY-2622 were
constructed in a similar manner from pGF-IVL1350, pGF-IVL1352, and pGF-IVL1353, respectively.
dEnhanced GFP (eGFP) contains S65T, F64L, R88Q, and H239L.
eContains 477 bp of CDC12 5′ UTR.
fThe following strains were constructed by first adding pGF-IVL1146 to WT BY4741 (GFY-2442) or WT BY4742 (GFY-2440) yeast. This “covering vector” expresses WT CDC11 with
21 codons mutated from their native code to an alternative codon (without changing the final protein sequence). Second, the endogenous CDC11 was deleted by transforming this
strain with a PCR fragment of cdc11∆::HygR with flanking 5′ and 3′ UTR (300 bp) amplified from a chromosomal preparation of GFY-155 and selecting for resistance to hygromycin and
lethality on media containing 5-FOA (loss of CDC11 renders cells inviable at 30◦C). Third, a plasmid was constructed using three rounds of subsequent in vivo ligation and homologous
recombination in yeast (Finnigan and Thorner, 2015) to assemble prCDC11::cdc11(357-415∆)::mCherry::CDC10 3′UTR::prGAL1/10::SpCas9::NLS::SHS1 3′UTR::prCCW12::KanR on
pRS315 (pGF-IVL1149). S. pyogenes Cas9 (yeast codon bias, CAI = 0.92) contains a C-terminal SV40 nuclear localization signal (SRADPKKKRKV) and is under transcriptional control
of the GAL1/10 promoter (814 bp). The cdc11(357-415∆) mutant contains 13 residues with alternative codons near the N-terminus and contains the CDC10 terminator sequence (465
bp). Cas9 contains the SHS1 terminator sequence (486 bp). The KanR MX cassette has been modified to remove the P(tef) constitutive promoter with the native yeast CCW12 promoter
(992 bp) which still allows for selection of resistance to G418 disulfide. This entire linear fragment containing both CDC11 and Cas9 was amplified in 2 separate PCR reactions with
overlapping sequence within the central region of Cas9 and co-transformed into the cdc11∆::HygR yeast also expressing the aforementioned covering vector. The CDC11 promoter
(330 bp) and MX(terminator) sequence (235 bp) provided homology to the native CDC11 locus to integrate the entire gene drive cassette. The Cdc11 C-Terminal Extension domain
(residues 357-415; CTE) is not required for septin filament formation (Versele et al., 2004) yet causes a severe loss of function when paired with shs1∆ or other mutations such as bni5∆
(Finnigan et al., 2015a).
gGFY-150 yeast (BY4742; cdc11∆::KanR ) or GFY-153 (BY4741; cdc11∆::KanR ) were transformed with a PCR fragment containing prCDC11::CDC11(WT)::GFP::ADH(t)::SpHIS5
(amplified from pGF-IVL1354) to create GFY-2624 and GFY-2625.
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TABLE 2 | Plasmids used in this study.
Plasmid Description References
pRS315 CEN, LEU2 Sikorski and Hieter,
1989
pRS316 CEN, URA3 Sikorski and Hieter,
1989
pRS425 2µ, LEU2 Christianson et al.,
1992
pCRTM-Blunt II-TOPO® TOPO II; pUC origin, KanamycinR, ZeocinR Invitrogen, Life
Technologies
pUC57a pUC origin, AmpicillinR Genscript
pGF-IVL845b pRS315;
TAP(link)::1xFLAG::Linker::GFP(β11)::ADH1(term)::KanR
This study
pGF-IVL890c pRS315;
TAP(link)::1xFLAG::Linker::GFP(β11)::SHS1(term)::KanR
This study
pGF-IVL985d pRS315;
TAP(link)::1xFLAG::Linker::GFP(β11)::SHS1(term)::prCCW12::KanR
This study
pGF-TOPO+IVL1204e TOPO II;
TAP(link)::1xFLAG::Linker::GFP(β11)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1205f TOPO II;
TAP(link)::1xFLAG::Linker::SpeI(site)::6xHIS::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1206g TOPO II;
prCDC11::NotI(site)::TAP(link)::mCherry(opt)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1207Cg,h TOPO II;
prCDC11::NotI(site)::TAP(link)::Nanobody(opt)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1208 TOPO II;
prCDC11::NotI(site)::TAP(link)::GST::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1209 TOPO II;
rCDC11::NotI(site)::TAP(link)::1xFLAG::Linker::3xHA::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1302i TOPO II;
prCDC11::NotI(site)::TAP(link)::NLS::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1303j TOPO II;
prCDC11::NotI(site)::TAP(link)::NES::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1304 TOPO II;
prCDC11::NotI(site)::TAP(link)::1xMYC::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1305 TOPO II;
prCDC11::NotI(site)::TAP(link)::MBP::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1306 TOPO II;
prCDC11::NotI(site)::TAP(link)::BirA(R118G)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1307k TOPO II;
prCDC11::NotI(site)::TAP(link)::CAAX::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1309 TOPO II;
prCDC11::NotI(site)::TAP(link)::SNAP::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1310l TOPO II;
prCDC11::NotI(site)::TAP(link)::SpHIS5::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1311g,m TOPO II;
prCDC11::NotI(site)::TAP(link)::mScarlet(opt)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1379g TOPO II;
prCDC11::NotI(site)::TAP(link)::eGFP(opt)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1380g TOPO II;
prCDC11::NotI(site)::TAP(link)::ymUkG1(opt)::SHS1(term)::MX(term)
This study
pGF-TOPO+IVL1381g,n TOPO II;
prCDC11::NotI(site)::TAP(link)::eGFP(opt):Lact-
C2::SHS1(term)::MX(term)
This study
pGF-IVL1251g,o pRS315; prCDC11::eGFP(opt)::CDC10(term)::MX(term) This study
pGF-IVL1252g pRS315; prCDC11::eGFP(opt)::ADH1(term)::HygR This study
(Continued)
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TABLE 2 | Continued
Plasmid Description References
pGF-IVL1253g pRS315;
prCDC11::ymUkG1(opt)::CDC10(term)::MX(term)
This study
pGF-IVL1254g pRS315; prCDC11::ymUkG1(opt)::ADH1(term)::HygR This study
pGF-IVL1255g pRS315; prCDC11::mCherry(opt)::SHS1(term)::MX(term) This study
pGF-IVL1256g pRS315; prCDC11::mCherry(opt)::ADH1(term)::HygR This study
pGF-pUC57+TAP(30)-STOP-
MX(term)p
pUC57; TAP(link)::MX(term) This study
pGF-TOPO+IVL1334q,r TOPO II; prMX::prSHS1::GFP(β10)::Linker::SacI This study
pGF-TOPO+IVL1335q,s TOPO II; prMX::prCDC11::GFP(β10)::Linker::SacI This study
pGF-425+IVL1274t,u pRS425; prSNR52::sgRNA(Kan-v1)::SUP4(term) This study
pGF-425+IVL1275t,u pRS425; prSNR52::sgRNA(Kan-v2)::SUP4(term) This study
pGF-V799t,v pRS425; prSNR52::sgRNA(TAP)::SUP4(term) This study
pGF-425+IVL1276t,u pRS425; prSNR52::sgRNA(GFP)::SUP4(term) This study
pGF-425+IVL1277t,u pRS425; prSNR52::sgRNA(mCherry)::SUP4(term) This study
pGF-V789w pRS316; prGAL1/10::SpCas9::NLS::CDC10(term) This study
pGF-IVL1146x pRS316; prCDC11::CDC11 This study
pGF-IVL1419 pRS315; prCDC11::CDC11::GFP(S65T)::ADH(t)::KanR This study
pGF-IVL1420 pRS315; prCDC11::CDC11::eGFP::ADH(t)::KanR This study
pGF-IVL1421 pRS315; prCDC11::CDC11::mCherry::ADH(t)::KanR This study
pGF-IVL1422 pRS315; prCDC11::CDC11::eGFP(opt)::ADH(t)::KanR This study
pGF-IVL1423 pRS315;
prCDC11::CDC11::ymUkG1(opt)::ADH(t)::KanR
This study
pGF-IVL1424 pRS315;
prCDC11::CDC11::mCherry(opt)::ADH(t)::KanR
This study
aThe TAP(link)::MX(term) sequence was synthesized de novo by Genscript (Piscataway, NJ) and subcloned into the EcoRV site of pUC57.
bThe TAP(linker) sequence includes the first 10 amino acids (GRRIPGLINP) of the TAP tag. A flexible Gly-Ser rich linker of 25 amino acids follows the FLAG epitope
(GSGAGGSPGGGSGGSGSSASGGSTS). Finally, the GFP(β11) strand (EKRDHMVLLEYVTAAGITDAS) precedes a STOP codon. The KanR cassette includes the standard P(tef) and
T(tef) sequences.
c Identical to pGF-IVL845 except the ADH1(term) has been replaced with 485 bp of the SHS1 3′ UTR sequence.
d Identical to pGF-IVL890 except the P(tef) promoter sequence from the KanR cassette has been replaced with prCCW12 (992 bp) from yeast.
eThe MX(term) or T(tef) from the KanR cassette (235 bp) was directly fused after the SHS1 3′ UTR sequence. Contains the same marker sequence as pGF-IVL890.
fA SpeI restriction site was inserted in-frame (residues TS).
gThe sequence (opt) has been optimized for expression in yeast.
hThe Nanobody domain (117 residues) has been developed against GFP.
iThe SV40 nuclear localization signal has the sequence SRADPKKKRKV.
jThe nuclear export signal is LAKILGALDIN.
kThe CAAX box motif is from yeast Ras2 with the sequence GSGGCCIIS.
lThe S. pombe HIS5 gene is the phenotypic equivalent of S. cerevisiae HIS3.
mThe mScarlet-I variant contains the mutation T74I and has a shorter maturation delay.
nThe Lact-C2 domain (158 residues) of bovine Lactadherin binds phosphatidylserine.
oContains 465 bp of the CDC10 3′ UTR.
pContains a STOP codon immediately following the TAP(link) sequence.
qThe N-terminal GFP(β10) strand contains the sequence MDLPDDHYLSTQTILSKDLN followed by 38-residue linker (DVGGGGSEGGGSGGPGSGGEGSAGGGSAGGGSKKKKAT). For
plasmid assembly, the linker sequence used for tagging ended with “...GGGSKK.” The prMX/P(tef) sequence contains 381 bp from the KanR cassette.
rThe SHS1 promoter contains 596 bp of 5′ UTR.
sThe CDC11 promoter contains 503 bp of 5′ UTR.
tThe sgRNA-expressing cassette was modeled after the Church Lab’s plasmid (DiCarlo et al., 2013) and synthesized de novo (GenScript). The cassette includes 269 bp from SNR52
promoter (Pol III), the 20 bp target sequence (crisprRNA) followed by the 79-base pair sequence for the fused (“single-guide”) tracrRNA and 20 bp poly-T SUP4 terminator sequence.
The target sequences were chosen based on minimal homology to the yeast genome using BLAST alignments (see Methods).
uFirst, the sgRNA 20 base pair target (crisprRNA) sequence was generated de novo using in vivo ligation and homologous recombination in yeast onto a CEN-based yeast vector.
Second, the sgRNA cassette was amplified and ligated into a TOPO II cassette (Invitrogen). Third, the cassette was subcloned to the high-copy pRS425 vector using flanking NotI/SpeI
sites on the TOPO II vector.
vFollowing sgRNA construction using in vivo ligation, the cassette was subcloned to pRS425 using BamHI/XhoI sites.
wS. pyogenes Cas9 was cloned with a C-terminal SV40 NLS tag and was placed under control of the GAL1/10 promoter (814 bp) and the CDC10 terminator (465 bp) using in vivo
ligation. Flanking NotI/SpeI sites were used to subclone Cas9 to pRS316.
xThere is no terminator sequence after the CDC11 STOP codon. Four Putative Cas9 targeting sites (23 bp each) have been mutated to include synonymous substitutions to create a
maximum mismatch to escape unintended Cas9 editing yet maintain WT protein sequence. The nucleotide changes include the +1 position of the CDC11 promoter, nucleotides 4–6, 9,
12, 15, 18, 21, 63, 66, 69, 72, 75, 81, 84, 1074, 1077, 1083, 1084, 1086, 1089, 1092, 1095, 1098, 1099, and 1101. A CDC11 gene was synthesized de novo (Genscript, Piscataway,
NJ) with the appropriate changes.
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based on the RNA polymerase III SNR52 promoter and SUP4
terminator (DiCarlo et al., 2013). A previously designed sgRNA
plasmid (Finnigan and Thorner, 2016) served as the template
for the common components [prSNR52, tracrRNA, SUP4(t)] for
all designed sgRNAs. Briefly, in vivo plasmid assembly (using
two unique oligonucleotides that inserted the 20 bp target DNA
sequence) was used to create the fully assembled sgRNA (e.g., to
target the TAP sequence) in a CEN-based plasmid. Second, the
sgRNA cassette was amplified and cloned into TOPO II. Third,
the cassette was subcloned to a high-copy yeast plasmid (pRS425)
using flanking restriction sites. DNAmaps for plasmid constructs
created in this study are included in Figure S2.
Culture Conditions
Yeast were grown on solid medium or liquid cultures that
included rich YPD (2% peptone, 1% yeast extract, 2% dextrose),
or synthetic basedmixtures (yeast nitrogen base with ammonium
sulfate) and the necessary amino acid supplements. Carbon
sources included either dextrose (2%), galactose (2%), or a
raffinose (2%) and sucrose (0.2%) mixture—filter sterilization
was used (rather than autoclaving) on all sugar types.
CRISPR/Cas9-Based Editing
Selection of Cas9 genomic targets was performed as follows
(Figure S3). For target genes (KanR, GFP, mCherry, and TAP
tag), possible PAM sites (5′-NGG-3′) were identified (on either
the coding or non-coding strand) and tested for their level of
mismatch against the S288C yeast genome. First, a search using
the NCBI Basic Local Alignment Search Tool database (BLAST)
with the 3′ most 15 bp of each putative site including the 3 bp
PAM sequence for themaximummismatch presented in the yeast
genome was performed. Previous work has demonstrated this
“seed” region (and PAM) are most significant in genomic target
specificity (Jinek et al., 2012; DiCarlo et al., 2013; Jiang et al.,
2013). A preference for target sites included (i) sequences whose
closest “match” in the yeast genome did not have a complete
3′ GG PAM sequence and/or (ii) contained many mismatches
across the 15 bp target site. Second, the entire 23 bp target
was also searched against the genome for the total number
of mismatches. Third, additional non-yeast sequences (plasmid
backbones, S. pyogenes Cas9 itself, drug cassettes, etc.) were
scanned for a maximum mismatch level. This selection process
reduces (or eliminates) the possibility of Cas9 “off-target” effects
which can be a major concern for editing if similar site(s) are
present within the genome of interest.
The S. pyogenes Cas9 was introduced into yeast strains on
a URA3-based CEN plasmid under control of the inducible
GAL1/10 promoter in a first transformation event prior to any
editing. This allows for (i) repression of Cas9 transcription
when yeast metabolize dextrose, (ii) optional counter-selection
on media containing 5-FOA, and (iii) stable propagation of the
Cas9-containing plasmid in all yeast cells (2–3 rounds of selection
in SD-URA medium) prior to addition of sgRNA-expressing
plasmid and donor DNA. Repression of the GAL1/10 promoter
sequence has been previously documented (Flick and Johnston,
1990). Additionally, separation of the sgRNA-expressing plasmid
and the Cas9 plasmid (added to yeast in a first transformation
event) prevents any possible Cas9 proteins from editing (no guide
sequence).
Activation of Cas9 and in vivo editing was performed as
previously described (Finnigan and Thorner, 2016). Briefly,
strains harboring the Cas9 plasmid (pGF-V789) were cultured
overnight to saturation in S+Raffinose/Sucrose-URA, back-
diluted to an OD600 of ∼0.30 OD/mL and cultured for 4.5 h
in YPGal at 30◦C. Cells were harvested and transformed or
co-transformed with 1,000 ng of sgRNA plasmid and, when
appropriate, 1,000–1,500 ng of donor PCR DNA. For PCR
fragments of slightly varied length, the appropriate amount of
product was adjusted accordingly. Following a heat shock at
42◦C for 45 min, cells were recovered at 30◦C overnight in
fresh YPGal, and plated onto selection media. For Cas9-based
editing (with or without donor DNA), the selection plates used
were SD-URA-LEU to select for the Cas9-based plasmid and the
sgRNA-containing plasmid and incubated for 3 days at 30◦C
before imaging. The total number of viable yeast colonies was
counted using a sectoring method in a single-blind protocol
(researchers counting colonies were not aware of the genotype of
each plate). Depending on the density of yeast colonies per plate,
either 1/4, 1/8, or 1/16 of the plate was sectored and individual
colonies were counted manually and extrapolated for the entire
surface of the plate (for smaller sectors, two or more separate
regions were tallied and averaged prior to extrapolation).
Confirmation of Cas9 editing (via NHEJ or by HDR) was
accomplished by (i) testing colonies from the transformation
plates on selection media (e.g., SD-HIS) to assay for absence of
the deleted selectable marker and (ii) obtaining clonal isolates
with the correct growth phenotypes on SD-URA-LEU plates,
and (iii) preparing chromosomal DNA and PCR amplification
with a high-fidelity polymerase. Finally, diagnostic PCRs and
DNA sequencing confirmed the presence (or absence) of the
appropriate gene fragments.
Cas9 Gene Drive and Containment
Experiments with the Cas9-based gene drive were performed
using the following protocol. First, the Cas9-containing gene
drive cassette was integrated into a haploid yeast strain.
Since the affected allele being tested (CDC11) is an essential
gene, a URA3-based covering vector (pGF-IVL1146) expressing
WT CDC11 was also present in these strains. Second, the
gene drive haploid strains were transformed with the sgRNA-
expressing plasmid but were cultured and maintained in the
presence of dextrose (to continually repress Cas9 transcription).
Third, yeast were selected twice on SD-URA-LEU medium
before being mated to the sample “target” strains expressing
CDC11::GFP::ADH1(t)::SpHIS5 at the native CDC11 locus of the
opposite mating type. While we have engineered the entire gene
drive system (covering plasmid and affected CDC11 allele) to
allow for the introduction of sgRNAs targeting the WT CDC11
gene coding sequence, we are compelled to demonstrate use
of the gene drive using a partially “artificial” target (in this
case, GFP fused to the WT CDC11 gene) for safety and ethical
reasons. Fourth, following mating on rich medium, yeast were
transferred (replica-plating on sterile velvet cloths) to SD-URA-
LEU-HIS plates to select for diploid formation (and to maintain
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the URA3-covering vector). Three consecutive rounds of diploid
selection (dextrose) were performed to ensure the absence of
any haploids and concurrent inactivation of the Cas9 drive—
moreover, even upon rare expression of Cas9, there would be no
target DNA sequence to initiate editing. Fifth, yeast were cultured
overnight in pre-induction media to saturation as previously
described (raffinose/sucrose mixture) selecting for the URA3-
and LEU2-containing plasmids. Sixth, cells were back-diluted
and cultured in YPGal for 24 h at 30◦C. Seventh, yeast were
centrifuged, washed in 1 mL of YPD, and diluted in sterile water
to∼250–500 cells per mL, spread onto SD-URA-LEU plates, and
incubated for 3 days. Finally, yeast were transferred from the
recovery plates to various drop out or drug-containing media to
test for the individual genotype(s) of single colonies.
A variety of safeguards were implemented to ensure proper,
safe, and contained use of these yeast gene drive strains.
Cultures containing the active (or pre-induced) gene drives
were immediately heated to 75◦C for a minimum of 3 h (and
usually overnight) prior to washing with water. The heated
cultures were rinsed with distilled water 3–4 times and all the
liquid (including rinses) was collected and autoclaved for 45
min at >121◦C. All plastic tubes, pipet tips, and any disposable
material was autoclaved before disposal and velvet cloths (for
replica-plating) were immediately autoclaved without rinsing.
Agar plates containing any combination of the Cas9 drive and
the sgRNA were only maintained until yeast were transferred to
the next step in the protocol; older plates were autoclaved prior
to disposal. All diploid strains generated from the gene drive
experiments were not preserved or frozen but were immediately
autoclaved and destroyed. With the only exception being the
liquid YPGal induction, all agar plates used contained dextrose
and actively repressed transcription of Cas9. The “target” selected
(GFP) is not a native yeast gene, and must also be present at the
CDC11 locus for the drive to copy itself within a diploid genome.
Moreover, the laboratory strain BY4741/BY4742 (BY4743) has
been shown by others to be extremely inefficient at sporulation,
even under optimal conditions that induce meiosis and spore
formation (Heasley andMcMurray, 2016). Finally, the high-copy
pRS425 plasmid harbored the sgRNA cassette—without constant
selection, this unstable plasmid is rapidly lost from yeast within
several days (our unpublished results) and has been previously
shown to be a useful safeguard to using gene drives in yeast
(DiCarlo et al., 2015).
Fluorescence Microscopy
Yeast were grown to exponential phase (A600 of 1.0 OD/mL)
in YPD culture at 30◦C, harvested, washed with water, and
prepared on standard microscope slides with a coverslip.
Samples were imaged within 5–10 min of slide preparation
on a Leica DMI6500 inverted fluorescence microscope (Leica
Microsystems Inc., Buffalo Grove, IL) with a 100x objective
lens, fluorescence filters (Semrock, GFP-4050B-LDKM-ZERO
and mCherry-C-LDMK-ZERO). A Leica DFC340 FX camera,
Leica Microsystems Application Suite AF software, and ImageJ
(National Institute of Health) software were used to obtain
and process all images. All images were treated identically
and rescaled together. The yeast cell periphery was determined
using either a DIC image or over-exposing a fluorescence
image. Representative cells were chosen for each image. White
light (DIC) was used to bring yeast into the plane of focus;
equivalent exposure times were used for all images within
a set.
RESULTS
Limitations of Commonly Used Marker
Swapping Systems
Given the recent expansion and utility of CRISPR/Cas9 gene
editing across many model systems, we sought to employ
this technology to provide the yeast community with a new
multipurpose molecular toolkit for strain construction. Previous
work has provided a suite of useful gene-tagging cassettes for
S. cerevisiae with the majority focused on either (i) biochemical
epitope tags (Tagwerker et al., 2006; Moqtaderi and Struhl, 2008;
Funakoshi and Hochstrasser, 2009) or (ii) fluorescent protein
variants (Sheff and Thorn, 2004; Lee et al., 2013; Malcova et al.,
2016). While these methodologies have been useful in both the
tagging of individual genes (when the need arises) or, in some
cases, the construction of entire yeast library collections, few
studies (Sung et al., 2008, 2013) have provided similar cassettes
for the use of modifying an existing library into a new/novel
collection. Moreover, the current strategy for “swapping” of one
tag or selectable marker for another is heavily centered around
the use of theMX-based drug resistant cassettes developed nearly
two decades ago (Longtine et al., 1998; Goldstein and McCusker,
1999). The utility of this cassette-based system lies in the common
universal promoter and terminator from A. gossypii which allow
for a common sequence among multiple drug or auxotrophic
markers (KanR, NatR, S. pombe HIS5, etc.). For instance, creation
of a HygR-tagged strain from the genome deletion collection
(KanR-marked) uses the flanking promoter and terminator
sequences as anchoring homology for themarker-swapping event
via homologous recombination. However, this alteration strategy
presents an unintended barrier in the conversion of previously
existing libraries that utilized the MX-based cassette strategy for
construction (e.g., GFP-ADH1-SpHIS5 or TAP-ADH1-SpHIS5).
We sought to illustrate this apparent conundrum and some of
the limitations of theMX-based marker swapping methodologies
most commonly used within the yeast community (Figure 1A).
Given the yeast TAP (Tandem Affinity Purification) tagged
yeast collection, we first designed an integrating cassette that
would append the C-terminus of any particular gene present
in the library with a 1xFLAG epitope, flexible linker, and
the short GFP(β11) strand of the tripartite split GFP system
(Cabantous et al., 2013; Finnigan et al., 2016; Figure 1A, top)
and also included the common ADH1 terminator and MX-based
KanR cassette. This general methodology has been previously
employed (Sung et al., 2008) and takes advantage of a short
stretch of bases present at the 5′ end of the TAP sequence.
Indeed, our system included exactly 30 base pairs of the TAP
construct (10 residues in frame) that would serve as the source of
upstream sequence homology. Additionally, the MX terminator
sequence would serve as the region of downstream homology
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FIGURE 1 | Chromosomal integration of a C-terminally tagged cassette into the TAP-tagged yeast library using homologous recombination. (A) Three constructs (V1,
V2, and V3) were PCR amplified (from pGF-IVL845, pGF-IVL890, and pGF-IVL985, respectively) and transformed into three yeast strains (GFY-1583, GFY-1589, and
GFY-1620) containing either KEL1, BUD3, or ELM1 tagged with the TAP marker (Figure S3). These integration cassettes (Table 2) allow for a C-terminal
1xFLAG-Linker-GFP(β11) tripartite split GFP tag (Finnigan et al., 2016) to be fused to any open reading frame that is part of the TAP collection. Each PCR contains a
30 bp universal segment of the TAP linker sequence as well as the full MX terminator; black dotted lines illustrate the expected homologous sections with the
chromosomal DNA. Additional identical sequences [e.g. ADH1(t)] also providing homology are illustrated with red dotted lines. Two universal primers (black arrows)
amplify the common TAP linker sequence (F1, “TAP Tag clone out F”) and the MX(t) sequence (R1, “MX clone out R2”) (Table S1). Unique diagnostic primers, red
arrows. Replacement of the prMX with the prCCW12 still allowed for G418 selection. (B) Quantification of the PCR integrations from (A) using both growth assays and
diagnostic PCRs. G418-resistant yeast were tested on SD-HIS medium (n = 100 colonies). From SD-HIS sensitive colonies, isolates (V1, n = 10; V2/V3, n = 8) were
selected and assayed by PCR as illustrated in (A). For V1, PCRs [F2, “KEL1 Internal +2908 F”/“BUD3 Internal +4381 F”/“ELM1 Internal +1455 F”; R2, “Internal
ADH1(t) R”] were performed; for V2/V3, PCRs (F2/R2 and F2/R3, “SHS1(t) R”) were assayed (Table S1). At least two isolates for each integration event were confirmed
via DNA sequencing.
for recombination and integration of the entire cassette into
the genome in place of the TAP tag and marker. However, our
system (V1) provided a significant segment of internal homology
[ADH1(t)-prMX; 627 bp] that could serve as an alternative HR
source for the introduction of the desired selectable marker
(KanR) in place of the SpHIS5 marker. Not surprisingly, while
100% of all G418-resistant colonies from the V1-integration
event (Figure 1B) had replaced the SpHIS5 marker within the
genome, <7% of total randomly-selected isolates tested across
three separate TAP-tagged strains (KEL1, BUD3, and ELM1) did
not include any of the desired sequence upstream of the KanR
cassette supporting the model that the internal homology present
within our integration cassette provided a significant source of
inappropriate homology that is greatly favored over the 5′ 30
bp desired TAP sequence. To further support this model, and to
provide a means to bias the HR-based integration event toward
the desired outcome, we designed a second cassette (V2) that
replaced the ADH1 terminator with the SHS1 3′ UTR sequence
(reducing the internal homology to 389 bp). As expected, the
percentage of isolates with the correct C-terminal tag and marker
increased to roughly 40% (Figure 1B). Finally, by replacing the
MX promoter sequence with the promoter of the constitutive
CCW12 5′ UTR sequence (V3) where the internal homology
was reduced to zero, the percentage of correct isolates was
increased to 75%. While our V3 system is one “traditional”
cloning solution to the issue of unintended cross-over, it is still
limited in utility due to the reliance on the existing marker-based
system.
While traditional HR-based strategies (Figure 1) can be
employed to circumvent the issue of inappropriate cross-over
with the MX-based tagging system, there remain some scenarios
where a designed integration cassette system is not compatible
with the yeast strain(s) to be manipulated. Examples of this
marker “conundrum” include (i) repeated use of many (if not
all) of the available drug resistance and nutritional markers
within the genome already or (ii) markers present on selectable
plasmids, or (iii) markers to be used for future methodologies
(such as SGA diploid selection). Therefore, in these cases,
a marker-less integration event would greatly aid in strain
construction. Moreover, removal of an existing marker already
present in the genome (e.g., TAP marked with S. pombe HIS5)
increases the pool of available markers for future selection or
construction. For these reasons, we sought to pilot various uses
a CRISPR-based methodology given the availability of universal
DNA sequences already present in many genome-wide libraries
or laboratory collections.
CRISPR/Cas9-Based Methodology for
C-Terminal Marker-Less Gene Tagging
We utilized the CRISPR system to provide a marker-swapping
strategy where (i) an efficient integration success rate could
be reliably achieved, (ii) a marker-less design could still be
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selected for with high fidelity, and (iii) the CRISPR components
(Cas9 and the sgRNA) could be optionally removed from the
designed strain following the editing event. Eight yeast strains
from the TAP-tag collection representing genes present on eight
separate yeast chromosomes were selected and transformed
with a URA3-based CEN-vector harboring S. pyogenes Cas9
under control of the inducible GAL1/10 promoter (Figure 2).
Second, a target sequence within the TAP tag was chosen with
a maximum mismatch to the yeast genome (Figure S3) and
the appropriate sgRNA cassette was constructed on a high-copy
LEU2-based vector (DiCarlo et al., 2013). Transformation of the
sgRNA plasmid into Cas9+ yeast (Figure 2A) and subsequent
selection on SD-URA-LEU medium demonstrated the efficiency
of editing in vivo. Yeast transformed with an empty pRS425
vector yielded many thousands of colonies following selection;
however, only a small number of viable yeast remained after
editing by Cas9. It has been previously demonstrated that the
DSB introduced by Cas9 is poorly tolerated in yeast (DiCarlo
et al., 2013; Finnigan and Thorner, 2016). The remaining
surviving colonies that had presumably undergone Cas9-based
editing and subsequent NHEJ were selected and tested by DNA
sequencing at their TAP-tagged loci. Indeed, while many isolates
did not display any detectible alteration from the WT sequence
(from either a lack of editing, or, more likely, editing and
repair by NHEJ without any remaining “scar”), 8/19 isolates
had deletions, insertions, or indels at the +3 position (the site
of Cas9 cleavage) upstream of the PAM sequence (Figure 2A,
bottom).
Given that editing by Cas9 in yeast is >99% lethal (the
few remaining colonies likely to have been repaired via NHEJ
or by escaping editing), we sought to combine the selection
for cell viability with introduction of a C-terminal tagging
cassette (Figure 2B). To further illustrate the utility of Cas9-
based integration in yeast, we designed a sample C-terminal
epitope tag cassette (1xFLAG-linker-6xHistidine) with the SHS1
terminator and the MX terminator sequence. Similar to our
initial methodology (Figure 1), the 30 bp TAP and MX(t)
sequences served as the only regions with homology to the
genome; these are also on flanking portions of the intended
Cas9-induced DSB and allow for HR across the chromosomal
break (Figure 2B). TAP-tagged strains expressing Cas9 were co-
transformed with the sgRNA(TAP) plasmid as well as PCR-
amplified donor DNA and selected on SD-URA-LEU medium—
many hundreds of surviving colonies remained on each plate
for each tested strain (Figure 2C). When individual isolates were
tested for loss of the SpHIS5 marker, between 75 and 100%
of each randomly-chosen sample removed (and replaced) the
endogenous marker (our unpublished data). Further analysis
by diagnostic PCR (Figure 2D) confirmed these edited, viable
colonies sensitive on SD-HIS plates had, in fact, integrated the
intended epitope tag in place of the original TAP tag without any
selectable marker present in 8 out of 9 strains tested: integration
FIGURE 2 | Use of CRISPR/Cas9 editing to C-terminally tag the TAP haploid library. (A) Targeting of Cas9 to the TAP tag sequence at various genomic loci induces
NHEJ. Eight yeast strains from the TAP collection (GFY-1583, GFY-1589, GFY-1620, GFY-2047, GFY-2056, GFY-2069, GFY-2071, and GFY-2092) were (i)
transformed with a Cas9 plasmid (pGF-V789), (ii) induced in galactose for Cas9 expression, (iii) transformed with the sgRNA plasmid (pGF-V799) targeting the TAP
sequence (Figure S3) or an empty pRS425 control vector, and (iv) plated to SD-URA-LEU plates (top). The total number of colonies was quantified on a log10 scale
(middle). Surviving colonies from the KEL1, BUD3, and ELM1 transformation events (+sgRNA) were sequenced at their TAP-tagged loci (bottom). The number of each
obtained genotype is illustrated. (B) As in Figure 1A, a C-terminal integration cassette containing a FLAG/His epitope tag and a 25-residue flexible linker (asterisk)
(see Table 3) was constructed. The TAP(30) sequence contains the first 30 bp of the TAP tag cassette. (C) Strains from (A) were transformed with the Cas9 vector,
the sgRNA(TAP) vector, and equimolar amounts (1,000 ng) of donor PCR DNA (F1, “TAP Tag clone out F”/R1, “MX clone out R2”), plated to SD-URA-LEU, and the
total colony count quantified. (D) Colonies (n = 30–50) from (C) were selected, tested on SD-HIS medium, and a representative isolate (n = 1) was selected (lacking
the S. pombe HIS5 marker) and assayed by diagnostic PCR. (F2, Gene-specific primers/R2, “SHS1(t) R”) (see Table S1). The expected PCR sizes (bp) are shown.
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TABLE 3 | Collection of C-terminal protein fusions for marker-less integration.
Plasmid (pGF) Marker(s) Description Size (amino
acids)
References
1204 1xFLAG-Linker (25)-GFP(β11) Biochemical Tag + Split GFP Taga 54 Hopp et al., 1988;
Cabantous et al., 2013
1205 1xFLAG-Linker (25)-SpeI-6xHIS Biochemical Tagsb 41 Hochuli et al., 1988
1206 mCherry(opt) Yeast Codon Optimized Fluorescent Proteinc 235 Shaner et al., 2004
1207C anti-GFP Nanobody Anti-GFP Protein Tetherd 117 Rothbauer et al., 2006;
Kubala et al., 2010
1208 GST Biochemical Tage 225 Benard and Bokoch,
2002
1209 1xFLAG-Linker(25)-3xHA Biochemical Tagf 65 Wilson et al., 1984;
Field et al., 1988
1302 NLS Cellular Localizationg 11 Kalderon et al., 1984
1303 NES Cellular Localizationh 11 Xu et al., 2012
1304 1xMYC Biochemical Tagi 10 Hilpert et al., 2001;
Krauss et al., 2008
1305 MBP Biochemical Tagj 375 Duplay et al., 1984
1306 BirA(R118G) Proximity-Dependent Protein Biotinylationk 321 Choi-Rhee et al., 2004;
Cronan, 2005
1307 CAAX Box Motif Cellular Localizationl 9 Mitchell et al., 1994
1309 SNAP tag Fluorescent Proteinm 182 Juillerat et al., 2003
1310 S. pombe His5 Cellular Growth Screeningn 216 Longtine et al., 1998
1311 mScarlet(opt) WT Yeast Codon Optimized Fluorescent Proteino 231 Bindels et al., 2017
1379 eGFP(opt) Yeast Codon Optimized Fluorescent Proteinp 237 Cinelli et al., 2000
1380 ymUkG1(opt) Yeast Codon Optimized Fluorescent Proteinq 227 Kaishima et al., 2016
1381 eGFP(opt)-LactC2 Yeast Codon Optimized Fluorescent Protein +
Membrane tetheringr
395 Andersen et al., 2000;
Shao et al., 2008
aFLAG Epitope, Flexible linker (GSGAGGSPGGGSGGSGSSASGGSTS), GFP(β-11) strand (EKRDHMVLLEYVTAAGITDAS).
bFLAG Epitope, Flexible linker (GSGAGGSPGGGSGGSGSSASGGSTS), SpeI restriction site (residues TS), and 6x Histidine tag.
cmCherry(opt); yeast optimization begins at residue 21; CAI (codon adaptation index) value = 0.92.
dAnti-GFP Nanobody; yeast optimized (CAI value = 0.84)
eGlutathione S-transferase (GST); sequence begins with “SPILGYW...” and ends with “...DLVPRGS.”
fFLAG Epitope, Flexible linker (GSGAGGSPGGGSGGSGSSASGGSTS), and 3xHA (Human influenza hemagglutinin) tag (YPYDVPDYAGYPYDVPDYAGSYPYDVPDYACG).
gNuclear Localization Signal (SRADPKKKRKV) SV40 Large T-antigen.
hNuclear Export Signal (LAKILGALDIN).
iMYC Epitope (EQKLISEEDL).
jMaltose Binding Protein (MBP); sequence begins with “KIEEGKL...” and ends with “...NSSSARL”. There is a XhoI (residues LE) restriction site preceding the stop codon.
kBirA(R118G); 35 kD DNA-binding biotin protein ligase in Escherichia coli.
lCAAX Box Motif (GSGGCCIIS) from yeast Ras2.
mSNAP Tag; 20 kDa mutant of the DNA repair protein O6-alkylguanine-DNA alkyltransferase.
nS. pombe HIS5 gene product; Imidazoleglycerol phosphate dehydratase HisB.
omScarlet-WT(opt) (CAI value = 0.93).
peGFP(opt); yeast codon optimization begins after residue 9 (CAI = 0.92). Contains S65T, F64L, R88Q, and H239L.
qymUkG1(opt) yeast codon bias (CAI = 0.92).
reGFP(opt)-Lact-C2; Bovine Lactadherin C2 Domain (158 residues) binds phosphatidylserine on the inner leaflet of the plasma membrane.
of the marker at the EPO1 locus was not successful for the single
isolate tested (our unpublished data). Through this study, we
have maintained a consistent selection criteria for assaying of
potentially edited yeast strains. As mentioned, we first assay for
a loss of the current genomic marker (typically S. pombe HIS5).
From clonal isolates that have lost this selection marker, we
have chosen to only interrogate a single sample by diagnostic
PCR and DNA sequencing to demonstrate the utility of our
system in the absence of all traditional selectable markers and
drugs. Subsequent to editing, expression of Cas9 can be repressed
by growth on dextrose whereas loss of the plasmid harboring
Cas9 can be achieved by selection on 5-FOA. In the absence of
continual selection on medium lacking leucine, the high-copy
plasmid containing the sgRNA cassette was rapidly lost (our
unpublished results). Removal of sgRNAs on 2µ plasmids has
also been previously documented (DiCarlo et al., 2015). While
we recognize our system includes use of two markers (URA3 for
Cas9 and LEU2 for the sgRNA), these constructs can be sub-
cloned to commonly used vectors (pRS series, etc.), combined
onto the same vector, or even integrated into the genome to
generate a new parental laboratory strain.
To expand the utility of our Cas9-based system, we
constructed 18 unique C-terminal tagged cassettes that can all be
integrated in place of the TAP tag (Figure 3A, Table 3). While
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FIGURE 3 | Collection of C-terminal marker-less tags for Cas9-based integration. (A) The proposed integration strategy illustrated in Figure 2A was used to
construct 18 C-terminal peptide or protein fusions (Table 3). (B) TAP-tagged KEL1, BUD3, and ELM1 (GFY-1583, GFY-1589, and GFY-1620) yeast containing Cas9
(pGF-V789) were co-transformed with the sgRNA(TAP) plasmid (pGF-V799) and equimolar amounts of PCR product (F1/R1) amplified from the 18 C-terminal tag
constructs (Table 2), selected on SD-URA-LEU plates, and the total colony count quantified for each event. Loss of the native S. pombe HIS5 marker was also
assayed (Figure S4). (C) Clonal isolates (n = 1) from each integration (lacking the original HIS5 marker) were assayed by diagnostic PCR (F2, Gene-specific F/R2,
“SHS1(t) R”). The relative PCR fragment sizes (bp) are illustrated (setting the first band for PCR “A” as 0 bp). The predicted sizes for PCRs are provided (Table S2).
Asterisk, the KEL1 locus was confirmed by DNA sequencing for all 18 integrations.
previous studies have focused primarily on either biochemical
epitope tags or fluorescent proteins, we have provided a far
more comprehensive molecular toolkit that should provide a
wide range of options for biochemical, cellular, genetic, and
microscopy-based assays. These include a variety of tags: (i)
codon optimized versions of eGFP, coral ymUkG1, mCherry,
and mScarlet, (ii) cellular localization signals such as a NLS,
NES, and a CAAX box motif, (iii) a sampling of commonly
used biochemical tags such as GST, MBP, (HA)3, and MYC,
and (iv) unique protein fusions, such as an anti-GFP nanobody
and a promiscuous BirA protein. To demonstrate the efficiency
of Cas9-based, marker-less integration, three sample TAP-tag
containing strains (KEL1, BUD3, and ELM1) were transformed
with all 18 possible donor DNA sequences (Figure 3B). Given
that identical conditions, sgRNA target sequences, and amplified
cassettes were used, we observed slightly varied efficiencies based
on the genetic locus being assayed—targeting and integration was
most successful at ELM1 locus with nearly 90–100% replacement
for all donor DNAs tested (Figure S4). Importantly, this
comparison—unlike the majority of other Cas9 editing studies—
can be directly made across loci since the target sequence (TAP)
and the sgRNA are identical and only the genomic placement
differs between editing events. Only a single isolate that was
pre-screened for loss of the native S. pombe HIS5 marker was
tested for each of the 54 integrations.We achieved a 100% success
rate when verified by diagnostic PCR and DNA sequencing
(Figure 3C, Tables S2, S4). For the S. pombe HIS5 gene (in-
frame) fusion with the target gene of interest, selection on SD-
HIS could not be used to determine if the TAP cassette had
been replaced since the resulting gene fusion may (or may not)
result in a cytosol-presented, functional His5 (budding yeast His3
equivalent) protein (Kel1 and Bud3 differed from Elm1 in this
respect). These results highlight the ability of Cas9-based editing
to be coupled with swapping of an existing tagged (TAP) library
to a variety of useful gene fusions in the absence of any selectable
marker with high efficiency.
Strategy for Marker-Less N-Terminal Gene
Tagging Using Universal Promoters
While previous studies have focused primarily on C-terminal
tagging cassettes (Longtine et al., 1998; Janke et al., 2004;
Lee et al., 2013) few groups have developed methodologies
for appending genes at their N-termini (Gauss et al., 2005;
Booher andKaiser, 2008). Two technical obstacles are responsible
for this bias toward C-terminal tags (and libraries). First, the
requirement of a selectable marker to follow the integration
event is easily added within the continuous sequence that can
include the (C-terminal) tag of interest, a universal terminator
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element, and a self-contained drug-resistance or auxotrophic
marker cassette (as described in Figure 1). This becomes more
challenging when attempting to introduce an N-terminal tag
and selectable marker. Attempts have been made to include the
marker cassette upstream of the endogenous promoter; however,
this requires re-engineering of the 5′ UTR and either replacement
or cloning of each individual promoter to drive expression of
the tagged gene(s). Second, even if a universal promoter (for
general, low, or over-expression) is chosen, each tagged gene of
interest must still have a unique set of oligonucleotides to deliver
the integration cassette to the desired locus. While this issue
can be circumvented when using an existing C-terminal tagged
yeast library to generate a new tagged collection (illustrated in
Figures 2, 3), no such N-terminally tagged set currently exists.
Therefore, we have developed a general strategy using Cas9
that could be used to generate an N-terminal tagged allele that
is (i) marker-less, (ii) under control of any chosen (one or
more) sets of promoters, (iii) requires a minimum number of
unique and/or extended (60 bp) oligonucleotides for cloning each
separate gene, and (iv) builds upon two existing yeast library
collections (Figure 4). To begin, a set of genes were chosen that
exist in both the TAP tag and genome deletion libraries (one
current limitation of this strategy as missing genes or essential
genes would not be usable). Next, yeast were transformed with
plasmid-borne Cas9 followed by co-transformation of the TAP-
targeting sgRNA and a donor DNA fragment that removed the
entire C-terminal tag and HIS5 marker (Figure 4A). Second,
chromosomal genomic DNA was used as the template to
amplify the entire gene including the MX terminator sequence.
A universal construct was also built that contained the MX
promoter sequence, one of two chosen promoters, the GFP(β10)
tag of the tripartite split GFP system (Cabantous et al., 2013;
Finnigan et al., 2016) and a repetitive Ser-Gly-based flexible
linker. This construct was used to generate an amplified fragment
containing a single (unique) oligonucleotide tail that extended
toward the N-terminus of the gene to be tagged (Figure 4A). This
method required use of the genome deletion collection (each gene
replaced with theMXKanR cassette) to provide a DSB over which
the multiple PCR fragments would reassemble the N-terminally
tagged gene. We tested two different sgRNAs to target the KanR
open reading frame (Figure S3) and examined their ability to
target three different loci (MSO1, APL1, and BNI4) (Figure 4B).
The sgRNA(Kan-2) target sequence resulted in more efficient
editing and was subsequently used for our N-terminal tagging
protocol. The genome deletion strains harboring Cas9 were
co-transformed with (i) the sgRNA(Kan-2) plasmid, (ii) the
amplified donor PCR containing the N-terminal tag and one of
two common promoters, and (iii) the entire amplified gene of
interest from the converted TAP-MX(t) strains (from Step 1).
Yeast were plated and selected on SD-URA-LEU, tested for
the loss of the KanR cassette, and the entire ensemble was
confirmed via diagnostic PCR and DNA sequencing (Figure 3C).
Our initial analysis (n = 1 isolate for the MSO1 and APL1
strains) demonstrated this protocol does allow for the universal
addition of tags at the N-terminus. While nearly 100% of
surviving colonies had lost G418 resistance (our unpublished
results), we observed several alterations in our DNA sequencing
FIGURE 4 | Cas9-based editing and yeast library conversion for a universal,
N-terminal tagging strategy. (A) Step 1: the TAP collection was edited using
Cas9 (pGF-V789), the sgRNA(TAP) (pGF-V799), and a donor PCR (F1/R1)
[amplified from pGF-pUC57+TAP(30)-STOP-MX(t)] to remove the entire TAP
cassette. Step 2: a N-terminal donor DNA cassette (left) was constructed
including a tripartite split GFP β10 tag, prSHS1 or prCDC11 sequence, and a
variable flexible linker (pGF-TOPO+IVL1334 or pGF-TOPO+IVL1335). Both (i)
the N-terminal tag (F2, “prMX clone out F”/R2, “GFP(β10)-Link-BNI4 R” as an
example) and (ii) the entire ORF fused to the TAP(30)-MX(t) (F3, “BNI4 clone
out F”/R1) from chromosomal DNA (from strains obtained in Step 1) were PCR
amplified. In some cases, large genes were amplified using overlapping PCR
fragments. Finally, targeting of Cas9 to the KanR sequence (genome deletion
collection) introduces a DSB; introduction of two (or more) amplified PCR
fragments allow for assembly of the N-terminally tagged gene and repair
across the break with no selection marker. (B) Two sgRNAs were created
(Figure S3) to target Cas9 to the KanR gene (top). Yeast deleted for MSO1,
APL1, or BNI4 (GFY-2251, GFY-2259, and GFY-2256) and harboring the Cas9
vector (pGF-V789) were transformed with either of the two guide RNAs
(pGF-425+IVL1274 or pGF-425+IVL1275) or an empty vector, selected on
SD-URA-LEU, and the number of colonies was quantified (bottom). (C) The
N-terminal tagging strategy (A) was performed for MSO1, APL1, and BNI4
with the described PCR fragments and the KanR sgRNA(2) plasmid. Colonies
obtained on SD-URA-LEU plates were tested for G418 resistance (n = 30–50)
and between 95 and 100% of all colonies had lost a functioning KanR
cassette. Clonal isolates (n = 1) sensitive to G418 were assayed by diagnostic
PCRs (primer combinations as shown, Table S1) and DNA sequencing of the
manipulated locus. The expected PCR fragment sizes are illustrated.
Oligonucleotides used included those within the promoter (SHS1/CDC11), the
gene of interest (F or R), and the MX(t). Additional loci tested can be found in
Table S4.
including a shortening of one of the repetitive Ser-Gly linkers
and the addition of a second initiator Met for our MSO1
assemblies. We expanded our initial set to include N-terminal
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tagging at 37 additional loci (Table S4). Across all 40 genomic
targets, or screening methodology resulted in a 75% success rate
(30/40) when assaying only a single isolate per event. One of
the technical challenges we encountered was the use of a long
flexible Ser-Gly rich linker sequence which contains repetitive
DNA sequences that could provide a source of inappropriate
cross over. While this methodology does not solve all existing
challenges to the genome-wide construction of N-terminal
tagged libraries, it does present a useful strategy for generating
chromosomally integrated, expression-modulated, and marker-
less sets with few required “unique” oligonucleotides–one of the
major construction hurdles for generating large sets of strains.
Using Cas9 to Replace Existing
Fluorescent Markers
Given the wide-spread use of fluorescent protein (FP) tags in
many areas of molecular and cellular biology coupled with the
discovery and development of new variants, it is surprising
that there is no current “upgrade” methodology described that
allows for efficient switching between FPs. This is a major
issue for both individual gene collections which have utilized
one or more FPs (either plasmid- or chromosomally-based) or
entire yeast libraries (e.g., GFP-tagged collection). Significant
study has been invested in the engineering of new fluorescent
variants to (i) include a wider visual spectrum including the
near infrared, (ii) have modified properties such as maturation
time, photostability, brightness, etc., or (iii) be utilized in
bimolecular fluorescence complementation type assays (BiFC),
such as FRET or split FP systems (Nagai et al., 2002; Rizzo
et al., 2004; Shaner et al., 2004; Pedelacq et al., 2006; Filonov
et al., 2011; Cabantous et al., 2013; Miller et al., 2015; Bindels
et al., 2017). The development of technical hardware (e.g.,
microscopes and digital cameras), computer software, and the
variations of usable proteins themselves has provided many new
options, but no method exists to rapidly and efficiently convert
one tagged collection into another (new) set. The traditional
means of cloning a new FP set into a collection (or library) of
yeast strains (or plasmids) still requires a significant number of
unique oligonucleotides, molecular cloning, and faces the same
technical issues for targeting previously C-terminally tagged
strains (Figure 1). Moreover, while some of the newest FP
variations require specialized microscopy components (allowing
for maximal use of the excitation and/or emission spectra of
the particular FPs) that might not be available for all users, a
simple solution already exists for the conversion of older GFP/FP
variants into more stable/readily expressed variants—alteration
of codon bias (Kaishima et al., 2016). The initial discovery
and implementation of FPs as well as the sharing of cloned
materials across laboratories has often resulted in an apparent
paradox—presence of the “upgraded” FP variant might suffer
from a poor codon bias for particular organisms as the FP may
have been evolved/developed for expression in a different model
system. Indeed, previous work tested a set of GFP variants in
a controlled setting (in budding yeast) varying only the codon
bias—this resulted in dramatically improved overall expression
and fluorescence intensities of the optimized FPs (Kaishima
et al., 2016). Thus, we developed a variation of our Cas9-based
methodology (Figures 2, 3) for upgrading of an existing FP-
tagged gene (GFP or mCherry) to a newer version or the same
version with an altered codon bias (Figure 5).
We examined six FP fusions to the yeast Cdc11 septin
protein in vivo at the division site (bud neck) by fluorescent
microscopy including GFP(S65T), eGFP, mCherry, codon-
optimized versions of eGFP andmCherry, and the coral ymUkG1
FP variant (Figure 5A). We designed a series of tester strains
with either GFP(S65T), eGFP, or mCherry placed at the same
genomic position (HIS3), all containing the common MX KanR
cassette to match many FP-tagged plasmids, integrated strains,
and genome-wide collections (Figure 5B). Next, we selected two
sgRNA sequences to target either GFP or mCherry at positions
very close to the N-terminus of each FP, but only matching
a sequence unique to the given fluorescent gene and not any
cloned linker region (Figure S3). We tested these sgRNAs for
their ability to recruit Cas9 to the intended site and induce
a DSB by transforming our set of engineered yeast strains
with plasmid-borne Cas9 followed by the sgRNA plasmid. As
expected, we found that DSB formation resulted in >99% of
yeast being inviable (Figure 5C). Importantly, expression of
the incorrectly matching guide RNA to the FP strain (e.g.,
sgRNA(GFP) in the mCherry-yeast strain) did not cause any
editing, demonstrating the chosen sgRNA target sequences
are unique and specific to each FP gene (our unpublished
results). Next, we developed a small set of donor DNA cassettes
that would allow for efficient, marker-less replacement of
the endogenous FP with the upgraded version(s) (Figure 5D,
Table 2). These included the coral ymUkG1 (Tsutsui et al.,
2008), eGFP (Cormack et al., 1996), and mCherry (Shaner et al.,
2004)—all synthesized de novo with an optimized yeast codon
bias. Expression of Cas9, coupled with co-transformation of
the appropriate sgRNA and amplified donor DNA allowed for
efficient generation of hundreds of colonies per integration event
(Figure 5E). Following a pre-selection assay to confirm loss of the
genomic marker (KanR), proper editing was confirmed by both
diagnostic PCR (Figure 5F) and DNA sequencing (n= 2 for each
editing event by DNA sequencing). Our Cas9-based FP-swapping
strategy is applicable to plasmid-driven or endogenously-tagged
genes as well as entire libraries and should provide a useful
means to merge many existing strains and collections with the
rapidly evolving field of fluorescence protein biology and its
many applications.
Application of a Cas9-Based Gene Drive as
an Alternative to Synthetic Genetic Array
(SGA)
Apart from our designed Cas9-based editing methods for tag
replacement, we explored a powerful arrangement of the nuclease
that could be applied to yeast library construction known as
a “gene drive.” Briefly, this organization of Cas9 requires the
nuclease gene to be present at a locus of interest (either replacing
and deleting an endogenous gene, or positioned proximal to the
native/modified gene) and a sgRNA that is designed to target
the WT copy of the gene on the opposite chromosome in a
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FIGURE 5 | Cas9-based strategy for upgrading fluorescent markers. (A) Yeast (GFY-42 or GFY-330) were transformed with vectors (pGF-IVL1419 to pGF-IVL1424)
expressing a fusion of the CDC11 septin to one of six GFP or mCherry variants and imaged by fluorescence microscopy. White dotted lines, cell periphery. Scale bar,
3 µm. (B) Three FP genes (GFP(S65T), eGFP, or mCherry) were integrated at the HIS3 locus under one of two promoters with a drug-resistance marker (bottom). Two
sgRNA cassettes were built (top) to target Cas9 to a target sequence in GFP or mCherry (Figure S3). (C) Yeast strains GFY-2613, GFY-2615, GFY-2617, GFU-2621,
and GFY-2622 (labeled 1–5) containing the Cas9 vector (pGF-V789) were transformed with either an empty (pRS425), sgRNA(GFP) (pGF-425+IVL1276), or
sgRNA(mCherry) (pGF-425+IVL1277) plasmid, plated on SD-URA-LEU, and the number of colonies was quantified in triplicate. Error, SD. (D) A marker-less
integration strategy to replace one FP with a different fluorescent variant and/or a codon optimized version of the same FP gene. Donor DNA included codon
optimized eGFP (from pGF-IVL1251), coral ymUkG1 (pGF-IVL1253), or mCherry (pGF-IVL1255). A unique terminator sequence for each donor construct allowed HR
to only occur within (i) common 30 bp upstream FP coding sequences and (ii) the MX(t). (E) Donor PCRs were amplified from (D) using universal primers (F1, “GFP
clone out F”/“mCherry clone out F” and R1, “MX clone out R2”) and digested with DpnI. Equimolar amounts were co-transformed into yeast strains 1–5 (C) with the
appropriate sgRNA vector, plated to SD-URA-LEU, and the colony count was quantified in triplicate. Error, SD. (F) Randomly selected isolates were tested for survival
on G418 and yeast lacking the KanR cassette (n = 2) were assayed by both diagnostic PCR and DNA sequencing. For strains (1–3), PCRs (F2/3 and R3) utilized DNA
primers to the promoter and newly introduced terminator sequences. For strains (4–5), two diagnostic PCRs (F2/3 and R2, F4, and R4) were performed to confirm
proper integration (see Table S1). The expected fragment size (bp) is illustrated.
diploid cell (Figure 6A). The presence and expression of both
Cas9 and the sgRNA induces a DSB on the WT copy of the
target gene; the source of donor DNA is the entire homologous
chromosome containing Cas9 itself (and, possibly, the sgRNA-
expressing cassette). The cell repairs the DSB by copying over the
engineered locus and propagating the Cas9 gene within a diploid
(Figure 6A). This technique is of particular interest to the fields
of insect biology, pest control, and the prevention and eradication
of insect-borne pathogens, such as malaria. Recent work in flies
and mosquitos has demonstrated that the Cas9 gene drive has the
potential to be used as a powerful biological agent for population
control (Gantz et al., 2015; Hammond et al., 2016). However, no
current studies have explored the use of a gene drive within basic
research except a single publication piloting the use of a Cas9
drive in budding yeast but did not include any demonstration for
strain generation (DiCarlo et al., 2015).
We envisioned that a gene drive might be repurposed
in S. cerevisiae for the goal of strain construction. To date,
two common methodologies are used in yeast for genome
manipulation. The first, and by far, the most widely utilized,
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FIGURE 6 | Use of a Cas9-based gene drive to deliver a recessive allele to a yeast library of the opposite mating type and convert to a homozygous diploid condition.
(A) General strategy for a nuclease-based gene drive. The “drive” consists of Cas9 placed at (or replacing) an endogenous gene. When paired in a diploid cell, Cas9 is
expressed and targeted by the sgRNA to the homologous WT gene creating a DSB. Alignment of the entire homologous chromosome serves as the source of donor
DNA to copy the gene drive. (B) Design of a gene drive for a recessive allele of an essential gene (CDC11). A URA3-based covering vector (pGF-IVL1146) expressing
a WT copy of CDC11 is present in the starting gene drive strain. Cas9 is under control of the GAL1/10 promoter and harbors a KanR marker; the entire array is
integrated at the CDC11 locus. A “target” strain (CDC11-GFP(S65T) fusion and the SpHIS5 cassette) was generated. The sgRNA(GFP) plasmid (pGF-425+IVL1276)
was transformed into the haploid gene drive strain (GFY-2442 or GFY-2440). (C) The status of each component (plasmids, ploidy, markers, drive activity, etc.) is listed
for each step. For a detailed description of drive activation, see section Materials and Methods. (D) Assaying for marker status on G418 and SD-HIS media of active
and non-active (empty vector) gene drive diploids. (E) Quantification of colonies from multiple diploid crosses (GFY-2624 × GFY-2440 and GFY-2625 × GFY-2442) in
triplicate. The percentage of surviving colonies (n = 250–500) is illustrated as “drive activity.” Error, SD. (F) Diploids strains (D) were imaged by fluorescence
microscopy. Dotted white lines, cell periphery. Scale bar, 3 µm. (G) Diploids (D) were selected on SD-LEU+5-FOA medium for 2 days at 37◦C. (H) Diagnostic PCRs
on diploids strains (D) (n = 2) and haploids strain controls (GFY-2624, “target” and GFY-2440, “drive”). Oligonucleotides (table) unique to the drive (red), target (blue),
or both, (black) are shown (also see Table S1). Expected PCR sizes (bp) are illustrated.
is simply transformation of amplified PCR donor DNA,
coupled with selectable markers to insert, modify, and/or alter
endogenous sequences based on homologous recombination.
This process occurs in yeast even in the absence of a DSB
(although the repair of DSBs on either plasmids or the genome
is increased by many orders of magnitude compared to intact
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native sequence). Second, following construction of libraries
or modified strains, combinations of alleles can be coupled
together by different methods including (i) mating strains of
the opposite type followed by diploid selection and sporulation
or (ii) successive rounds of traditional transformation events.
In response to the creation of many yeast libraries and the
development of robotic and semi-autonomousmethodologies for
manipulating yeast strains, the “synthetic genetic array” (SGA)
protocol was developed (Tong et al., 2001). Briefly, this method
combines a query strain (harboring a desired allele or deletion
of one gene) and combines it with an entire yeast library of
choice (GFP, deletion collection, etc.) into a haploid strain in a
high-throughput fashion. However, the “full” SGA protocol has
some restrictions (both technical and genetic). First, a unique
genetic background must be utilized to allow for subsequent
haploid selection steps. Second, the entire protocol requires
between 3 and 4 weeks for the procedure from start to finish,
excluding the selection of clonal isolates. Third, the process
requires additional exogenous components for ploidy selection
and the use of selectionmarkers. However, we envisioned that for
some scenarios, combination of a query gene of interest and the
modified library would not need to be assayed within a haploid
cell, and, instead, a diploid state would be sufficient (e.g., only
the first two steps of an SGA-type protocol). Examples would
include over-expression arrays or FP-tagged libraries (GFP); in
both cases, obtaining the haploid state may not be required
nor cause a significant difference in the final assay. It is very
likely that the query allele (commonly a hypomorph) of interest
must be expressed as the only copy within a diploid; therefore,
achieving the homozygous state may be essential. Of note,
even recent genetic screens (Berry et al., 2016) run into this
same issue—one of the two components of their GFP/anti-GFP
nanobody tethering system is plasmid-expressed and thus has
a WT endogenous copy still present within the genome (that
may alter or confound the interpretation of results). The diploid
selection method, as described by a SGA-type protocol, is unable
to provide two copies of any query allele.
Therefore, we have provided a detailed account of the design
of a common gene drive installation protocol and tested its
effectiveness at generating the homozygous diploid state. To date,
this “Super-Mendelian” arrangement is the only methodology
that would be able to rapidly convert a heterozygote into a
homozygous condition within an individual diploid genome.
Furthermore, we have chosen an essential gene to illustrate
the breadth of alleles that are possible within this same Cas9
arrangement. We generated a “cargo-based” gene drive and
integrated the entire construct at the native CDC11 locus
(Figure 6B). The design of our constructed gene drive plasmid
(Table 2) also allows for introduction of any other yeast gene in
place of our chosen CDC11 allele for immediate application. This
strain harbored (i) a URA3-based covering vector to protect the
strain from the loss-of-function cdc11 allele we chose to include
as the “cargo” and (ii) the sgRNA targeting the GFP sequence
we previously designed (Figure 5). We have also included the
(optional) selectable KanR marker to assay the presence of the
drive. For biosecurity reasons, we have chosen to pilot application
of this gene drive in a strain harboring CDC11-GFP at the native
CDC11 locus in strains of the opposite mating type that were also
tagged with the S. pombe HIS5 marker (for clarity in assaying
“success” of the active drive). The procedure would be identical
in all ways when/if the gene drive was targeted to the native
CDC11 gene (rather than the exogenous GFP sequence).We have
illustrated the othermodifications needed to target the nativeWT
gene including alteration of the codon sequence of the putative
Cas9 target site(s) within (i) the covering vector and (ii) the cdc11
“cargo” allele (Figure 6B, Tables 1, 2).
Following design of the gene drive (created in bothMATa and
MATα yeast), we have developed a protocol to allow for rapid
activation of the drive followed by isolation of clonal diploid yeast
colonies in only a few days (Figure 6C, Figures S5, S6). Activation
of Cas9 (and the gene drive) resulted in>99% of all sampled cells
(nearly 500 cells per plate) having lost the endogenous CDC11-
GFP-HIS5 target gene followed by full replacement of the gene
drive itself (Figures 6D,E). Individual clonal isolates from both
the active drive-containing strain and a control strain were tested
for their ploidy status (haploid or diploid) and all sampled yeast
were properly in the diploid state (Table S3). Compared to the
starting haploid strains (Figure S6), diploid yeast harboring the
empty vector and no sgRNA cassette expressed both the GFP
and mCherry-tagged Cdc11 proteins (Figure 6F, top) whereas
cells following activation of the gene drive had lost all Cdc11-
GFP signal (Figure 6F, bottom). Moreover, loss of the CDC11-
expressing URA3-marked covering vectors by growth on 5-FOA
(Figure 6G) demonstrated successful action of the gene drive.
Expression of the cdc11-CTE∆-mCherry allele in a haploid cell
as the only copy of CDC11 renders yeast temperature sensitive
at 37◦C (Finnigan et al., 2015a). Finally, diploid genomes were
isolated and examined by extensive diagnostic PCR illustrating
the loss of target components and the copying of the entire
drive to the homologous chromosome (n = 2 isolates for
each diploid drive) (Figure 6H). This methodology could be
coupled with several yeast library variants harboring (i) over-
expression vectors, (ii) the GFP library, or (iii) other yeast
collections that have been generated within either mating type.
These results demonstrate the utility and success of a Cas9 gene
drive for obtaining a homozygous diploid status for a desired
allele—this strategy could be utilized by many model systems
outside of yeast for bypassing time-consuming strain/organism
construction steps (multiple generations, selection steps, etc.) by
traditional methodologies.
DISCUSSION
The Marker-Less Option
The yeast research community has pioneered the use of genetic
screens (forward and reverse) including the development of high-
throughput automated SGA and high-content screening (HCS)
technology. S. cerevisiae has been utilized to generate numerous
types of genome-wide libraries and explore a range of biological
questions including genetic interactions (Costanzo et al., 2010,
2016), protein-protein interactions (Tarassov et al., 2008; Sung
et al., 2013), and transcriptional modulation (Mnaimneh et al.,
2004; Rajkumar and Maerkl, 2012). However, the introduction of
CRISPR/Cas9 in budding yeast has been met with a lukewarm
Frontiers in Microbiology | www.frontiersin.org 17 September 2017 | Volume 8 | Article 1773
Roggenkamp et al. CRISPR Method for Yeast Generation
reception. One possible reason is that the primary nuclease-
dependent function of Cas9 is to generate targeted DSBs and
allow for recombination into genomes of interest—something
that budding yeast are capable of in the absence of any DSB.
Indeed, we demonstrate in Figure 1 that traditional cloning in
yeast can provide solutions to some of the issues surrounding
strain construction. However, recent work has demonstrated that
yeast can still benefit from use of CRISPR-based editing and, as
we have shown, can be coupled with the genome-wide library
infrastructure that has been available for nearly two decades to
greatly aid in strain construction. Moreover, the use of Cas9 can
provide a powerful selection tool—cell viability, that can be used
for screening sans any selectable marker cassette.
It is surprising given the enormous amount of genome-
wide (or sub-genome) yeast collections that exist and continue
being generated that few groups have focused on library
conversion rather than de novo development. There are still
serious technical and costly challenges for building an entire
tagged library (or large set of yeast strains in the many hundreds
or thousands) including the cost of oligonucleotides (minimum
of two extended DNA primers for each locus being targeted),
high-throughput manipulation of many yeast strains (although
this is an optional addition), and verification of the final
manipulated genomes. Automation and the development of
hardware that can aid in bulk transformations or mating events
have addressed the logistical challenge of handling thousands of
strains simultaneously (Tong et al., 2001; Liu et al., 2017). The
major benefit of utilizing an existing library is that the placement
of common sequences (e.g., C-terminal tag, terminator, selection
marker cassette, etc.) has already been invested and verified.
Thus, “universal” oligonucleotides can be used to amplify and
target every modified locus within the collection. However,
additional alterations must be considered when preparing the
donor DNA cassette that would replace the existing tag/marker
including the presence of common sequences that are often
utilized as part of the MX drug/auxotrophic marker. Neglecting
these sequences may, as we have demonstrated in this study,
result in false positives during the marker “swap” integration
event. Furthermore, the few published strategies to date for
library conversion require the use of a (different) selectable
marker to be inserted in place of the existing one or prevent
unintended “swapping” betweenmarkers (Sung et al., 2008, 2013;
Wosika et al., 2016).
The ability to have a “marker-less” genetic alteration is
often desirable, but can also present technical challenges. Prior
to the introduction of CRISPR/Cas9, there have been other
systems used to remove a selectable marker (often in at
least two or more consecutive steps) using integration vectors
(Sikorski and Hieter, 1989), the Cre-Lox system (Germino
et al., 2006), or other methods, such as the classic “loop in-
loop out” (Landgraf et al., 2016; Wang et al., 2017). This is
often extremely useful in strains where the presence of multiple
plasmids and multiple loci have all been (each) marked with
the entire ensemble of selectable markers in yeast (or if a
particular genetic background does not include the full suite of
auxotrophic knockouts). Our methodology provides a number
of advances over current cloning systems. First, our developed
system utilizes (i) the developed yeast libraries currently available
and (ii) CRISPR/Cas9 editing to provide a single-step, seamless
integration sans any selectable marker. The selection generated
by introduction of the DSB (viability) is sufficient to obtain
correct isolates from a very small sampling pool—further
optimization and development could utilize our strategy for
the development of entire libraries. Second, our methodology
could be performed in conjunction with the traditional selectable
markers should the need arise (following the genetic locus after
sporulation, etc.). Third, our system allows for rapid removal of
the CRISPR components—theURA3-based Cas9 can be counter-
selected on 5-FOA, and the sgRNA is rapidly lost on a high-copy
plasmid. While our experiments utilized the URA3 and LEU2
markers for harboring Cas9 and the guide RNA, other options
exist should either of these genes be required in the selection
process (e.g., cloning Cas9 to a different CEN-based vector or
direct integration in the parental strain). Fourth, our strategy
could be employed in strains that already contain numerous
other genetic alterations (tags, FPs, selectable markers) with
virtually no unintended HR events (which would not be the
case for the majority of the other C-terminal tagging cassette
strategies that currently exist which rely on selection cassettes).
Fifth, one of the major advantages of using CRISPR/Cas9 is
the ability to multiplex—editing numerous genes simultaneously
with exacting precision. None of the previous tagging strategies
allow for tagging of more than a single gene per transformation
event. CRISPR/Cas9 has been shown to allow for targeting of
many loci in yeast with great accuracy and precision in a single
step (Ryan and Cate, 2014; Bao et al., 2015; Horwitz et al.,
2015; Finnigan and Thorner, 2016). Likewise, our system is fully
capable of using two or more sgRNAs to target more than one
loci at a time for editing, tagging, or marker-removal. Finally, in
scenarios requiring two or more of the same marker (e.g., KanR)
to be used to mark a large number of deletions or loci, growth
selection would no longer serve as a convenient means to assess
the presence (or absence) of a particular modification and would
require genomic interrogation of some sort. The ability to have
a suite of selectable markers to tag different loci is a convenient
and powerful tool in yeast and other model systems. However,
the ability to manipulate a genome in the absence of any marker
(which can then be used for other loci, or plasmid selection)
provides more utility in strain construction and can allow for the
generation of more complicated strains as the need arises.
An Expanded Molecular Toolkit
Previous studies describing molecular cassettes for gene tagging
narrow their focus to (i) either the N- or C-termini of a gene,
(ii) the inclusion one or more options for growth selection,
and (iii) provide a common theme for the type of gene
fusion (e.g., biochemical epitopes, FPs, etc.). Here, we provide
a diverse sampling of commonly used tags but also include
cellular localization signals (CAAX box motif, NLS, NES, Lact-
C2 domain) and fusions that could be used for cellular assays
and future genetic screens (mutant BirA, SNAP tag, anti-GFP
nanobody domain, tripartite split GFP system, and the S. pombe
HIS5 gene) (Table 3). This collection should provide the yeast
community with an expanded set of options for construction of
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both individual strains as well as entire genome-wide libraries.
For instance, the utility of the GFP/anti-GFP nanobody pairing
has been previously demonstrated (Berry et al., 2016) yet no
such nanobody-tagged collection exists (the authors utilized the
GFP library and a plasmid-expressed nanobody-fusion query
set). Our toolkit is by no means saturated and future iterations
might also include additional localization signal motifs, epitope
combinations, and the ever-expanding collection of genetically-
encoded fluorescent proteins.
One unique feature of our design is the ability to subtly
alter, or completely “upgrade” an existing C-terminal fluorescent
marker (either within a single strain or within, say, the GFP-
tagged collection) with a codon optimized version of either the
same FP, or a new one. While new FP are being discovered
and engineered that allow for new capabilities such as four-
color imaging (Filonov et al., 2011; Lee et al., 2013), increased
brightness (Bindels et al., 2017), BiFC (Cabantous et al., 2013),
and other controlled functions such as degradation (Houser et al.,
2012), there is a paucity of molecular tools to allow for rapid
inclusion of these FPs into existing systems. For older libraries,
such as the yeast GFP collection (Huh et al., 2003), or for cloned
plasmids or yeast strains from just a few years ago, a modified
FP fusion might be required for better detection, multi-color
imaging, stability, or other engineered properties. Therefore,
methods need to be developed to bridge the expanded FP toolkit
with strains (or plasmids) that already contain a cloned FP (or
tag). The idea of providing the yeast community with new FPs
with expanded markers is not a new one. Indeed, numerous
studies have already focused on newly engineered green and red
(and other) FP variants for traditional HR-based integration and
cloning into the yeast genome (Sheff and Thorn, 2004; Vorvis
et al., 2008; Lee et al., 2013; Slubowski et al., 2015; Malcova
et al., 2016). However, all of these previous studies do not address
the major issue at hand—the enormous investment of having to
generate de novo the desired gene fusions, collections, or library
which comes with the same technical and logistical restrictions
(oligonucleotide investment, presence of a selectable marker,
and promiscuous integration into strains already containing
(other) cassettes). Finally, the sharing of new FP materials across
disciplines and model systems has led to situations where a newly
developed fluorescent protein might be expressed with the wrong
codon bias in a given species. Even though the cost and utility
of gene synthesis is growing more manageable and mainstream,
many researchers choose not to re-synthesize de novo the entire
exogenous FP tag for optimal expression in their given species
(even though this should now become standard practice).
Therefore, our methodology has demonstrated both
concepts—codon optimization using the same FP, or insertion
of a newer variant in place of an older one (ymUkG1 in place of
GFP). Our Cas9-based editing—unlike other “standard” cassette-
based strategies—can be applied to editing of the genome or
editing of existing plasmid-borne constructs. Cas9 paired with
the appropriate guide RNA would target, create a DSB within
the (existing) FP tag, and, given the presence of the MX-based
cassette on the plasmid (which, again is most common-place
for construction using existing tagging strategies), would allow
for repair and re-circularization of the plasmid with no added
selectable marker. The ability to edit both the genome and
plasmids is unique to our Cas9-based editing and would not be
possible with any of dozens of other tagging methodologies that
are purely intended for targeting of the genome. While we chose
to limit our FP-swap within the same color spectrum (green to
green, red to red), future iterations might consider altering any
FP to any other FP to provide maximum choice in experimental
design and application.
Novel, Simplified Application of
CRISPR/Cas9 Editing in Yeast
To date, the majority of CRISPR-based applications in yeast
and other systems have accepted the “one genomic target, one
sgRNA” strategy as dogma. However, several studies have begun
to expand beyond the idea of using multiple sgRNAs to target
multiple locations. This concept has been useful in targeting a
nuclease dead (dCas9) variant to naturally-occurring repeated
sequences (such as delta elements or telomeres) in living cells to
recruit sufficient dCas9-FP fusions to be able to visualize nuclear
structures in real time (Ma et al., 2015; Dreissig et al., 2017).
Similarly, targeting of constructed gene fusions to commonly
repeated sequences has been done to deliver entire libraries
of gene fusions (to the same genomic position) in a high-
throughput automated system (Si et al., 2017). However, the
idea of using a minimal number of guide RNA constructs to
target many loci has not been widely used (or used at all).
Here, we have developed four critical sgRNA constructs to target
universally-used sequences that are found in most engineered
yeast strains from all laboratories, and several of the most utilized
yeast libraries: GFP, mCherry, TAP, and the KanR deletion
cassette. Using only these four sgRNA plasmids, one could
target an extreme number of loci across library collections, SGA
haploid sets (numbering in the millions), and, most importantly,
individual laboratory strain collections.
We recognize that our C-terminal tagging strategy likely has
the most utility for application within the yeast community;
in contrast, our N-terminal tagging scheme still requires
some additional gene-specific components. However, our pilot
methodology has demonstrated an attempt to minimize gene-
specific reagents (oligonucleotides) while still utilizing existing
yeast strains. Three current limitations of our N-terminal system
include (i) the required use of a “common” promoter to drive
expression, (ii) the presence of the modified gene in both the TAP
and deletion libraries (our current methodology must exclude
all essential genes), and (iii) gene-specific reagents. However,
our primary goal for this study was to demonstrate that use of
Cas9 paired with a “universal” guide RNA could allow for a
variety of cloning techniques aside frommerely the traditional C-
terminally tagging scheme. By coupling a pre-selection step (e.g.,
loss of the S. pombe HIS5marker) to assess loss of the endogenous
marker and sampling a single isolate, we have demonstrated a
high success rate (100%) for our FP swapping or C-terminal
tagging strategies. However, given testing at 40 separate genomic
loci, our N-terminal tagging method still achieved a modest 75%
success rate. Based on these results, we propose that application
of our CRISPR-UnLOCK strategy include the pre-selection step
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on a small number (3–4 colonies) to ensure targeting of the
correct locus. From this subset, we envision that verification of
engineered strains also only require 1 or 2 clonal isolates for
further testing. Clearly, the construction of genome-wide sets
of strains is an ambitious endeavor and many yeast libraries
have encountered difficulty in targeting particular loci and as
a result, do not contain the full complement of non-essential
genes. We envision the greatest utility of our method to the
construction of individual yeast strains (rather than full libraries)
with an emphasis on scenarios requiring marker-less tagging or
complicated strains where traditional methods have too many
technical restrictions.
One of the widely recognized limiting steps in performing
CRISPR-based editing is the construction of the particular
sgRNA-expressing cassette since the same Cas9 nuclease is
commonly used, and, in many cases (mostly outside of yeast), no
donor DNA is required. Therefore, we have approached the issue
by targeting Cas9 to multiple universal sequences that populate
most yeast strains today—this sets our CRISPR methodology
apart from all other studies using this editing technology that
are limited to the “one sgRNA, one target” mechanism. For those
few studies that utilize natively repeating sequences (such as delta
elements) within the genome, they are not able to tag or target
endogenous genes at other loci. Thus, our study provides the
first widely applicable, practical use of Cas9-editing tomanipulate
existing yeast strains (individual collections or libraries). This
combines the power of CRISPR with the most commonly used
markers and tags already present in nearly every lab strain
published in the last two decades. Our CRISPR system does not
replace traditional HR-mediated targeting and integration, but
provides a diverse set of options for future strain development
and greatly complements existing methodologies including SGA.
Previously, we demonstrated the use of artificial 23 bp DNA
sequences, installed within the yeast genome, to multiplex and
recruit Cas9 using only a single sgRNA construct (Finnigan and
Thorner, 2016). These non-traditional Cas9 targeting events to
universal (or artificial) DNA sequences could easily be adopted
and applied by other fields outside of budding yeast. We will
continue to expand the utility of this toolkit by including other
commonly used sequences (from auxotrophic markers, selection
cassettes, and other widely used tags) to provide more strain
development choices to the yeast community.
CRISPR-Based Gene Drives Can Be Used
in Strain Generation
We have included the use of a gene drive to illustrate a non-
traditional application of the CRISPR editing technology that
can also be combined with yeast library sets. While most high-
throughput applications rely on the SGA protocol to combine
alleles of interest and, ultimately, achieve a final haploid state
(removing both WT copies of the two genes), some assays
can simplify this process by utilizing a diploid yeast strain
(e.g., halting the SGA protocol after diploid generation). For
over-expression libraries (plasmid-borne), the contribution of
the native WT gene is often inconsequential. Moreover, for
use of the GFP-tagged collection to visualize localization of
a gene product, a second unlabeled WT copy of the protein
may reduce the overall fluorescence intensity (since only half
of the protein would be fused to GFP), but would not alter the
overall localization pattern. In these cases, the major technical
hurdle remaining is achieving a homozygous diploid state for
the desired query allele—the contribution of a second WT copy
could drastically alter or mask the phenotype(s) of the final
strain since most queries would likely be hypomorphs. Therefore,
we piloted the use of a gene drive to carry out this specific
function. Indeed, our described use of a gene drive is the first
to achieve a homozygous state in a diploid for strain generation.
The major difference between traditional transformation-based
manipulation of each strain (individually) and an “automatic”
active gene drive would be that no further yeast transformations
would be required—all components for copying the gene drive
and the proximal “cargo” allele of choice would be inherent to
the initial starting strain. Furthermore, we have demonstrated
the system is extremely robust and efficient with >99% of
diploid cells being converted to the homozygous condition in
24 h following active expression of Cas9 and verified by four
independent assays. By comparison, the (full) SGA protocol
requires many weeks of sporulation and subsequent selection
steps to achieve the desired haploid state. We envision that
application of this gene drive strategy within a diploid strain
could be very easily and rapidly performed with a library of
choice (construction of the query strain would be the limiting
step).
We have taken great care to keep our Cas9 gene drive
system self-contained and controlled as we recognize that
FIGURE 7 | Summary of four CRISPR/Cas9-dependent methodologies for gene editing in yeast. The use of Cas9 editing (DSBs illustrated) for introduction of new
markers into various yeast libraries sets. N-terminal tagging utilizes the TAP tag and deletion collections; C-terminal tagging utilizes the TAP collection, and the GFP
library can be targeted to upgrade FPs. A Cas9 gene drive arrangement allows for rapid generation of a homozygous diploid state for a query allele including essential
genes.
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even in budding yeast, this particular CRISPR arrangement
has the potential for unintended release or action. We have
detailed numerous safeguards that have been imposed on our
experimental design and execution (see Materials and Methods)
with the most significant being use of an “artificial” target strain
containing GFP at the CDC11 locus (rather than an unmodified
WT allele). We are confident that as additional arrangements
and safeguards (DiCarlo et al., 2015) are investigated and
explored, the use of gene drives within the laboratory setting (and
elsewhere) might be seriously considered for strain generation,
library construction, or ecological control in a manner that is
ethically and logistically safe and regulated.
These CRISPR-based methodologies for construction of S.
cerevisiae strains (Figure 7) could be applicable to other model
systems and hopefully aid in the development of new techniques.
Targeting of Cas9 to universal sites within a previously generated
library or organism for tagging, upgrading or replacement of
existing FPs, use of marker-less genomic integration, and the
efficiency of a “gene drive” arrangement to achieve a homozygous
diploid state for a query allele are all strategies that could be
applied to many other biological systems.
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